Mergers and Acquisitions

BREAKING: Del. Justices Uphold Fresenius' $4.3B Akorn Merger Drop

One day after hearing appeal arguments, Delaware's Supreme Court upheld on Friday a milestone Chancery Court finding that Fresenius Kabi AG had a right to walk away from a $4.3 billion agreement to buy generic drug developer Akorn Inc., based on "material more